A federal court in Texas has ordered Pharm D Solutions to stop producing or distributing compounded drugs intended to be sterile until the company complies with federal law and other requirements, the Food and Drug Administration announced. In addition, a federal court in Illinois prohibited PharMedium Services from making or distributing compounded drugs from its Tennessee facility until it takes corrective actions. PharMedium Services also must hire an independent expert to review operations at its Texas and New Jersey facilities to ensure compliance with the law, FDA said.